» Articles » PMID: 34956405

A Pragmatic Pilot Cluster-Randomized Study of Tobacco Screening and Smoking Cessation Program for Community Pharmacies in Japan: FINE Program

Overview
Journal J Smok Cessat
Date 2021 Dec 27
PMID 34956405
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the effectiveness of a smoking cessation program (FINE program) in community pharmacies.

Methods: A cluster-randomized controlled trial was conducted in 11 community pharmacies in Japan. The participants were randomly assigned to a pharmacist-led structured smoking cessation program (intervention group) or pharmacist-led usual care (control group). The intervention group was followed up over the telephone on the third day of smoking cessation, and ongoing follow-up and advice were provided according to the original smoking cessation guidebook developed for the current study based on a behavioral change approach. The control group received brief advice and ready-made pamphlets on smoking cessation from pharmacists upon their visit to these community pharmacies. The primary outcome was continued smoking cessation as determined by self-reporting and carbon monoxide monitoring with a microsmokerlyzer after 3 months.

Results: Five hundred and seventy-two smokers who met the eligibility criteria visited the pharmacies included in the study. Of these individuals, 24 patients agreed to participate in the study. The quit rates were 45.5% and 18.2% in the intervention and control groups, respectively ( = 0.380, effect size = 0.60).

Conclusion: Based on the effect size values, the FINE program may be effective to some extent, but the difference was not significant. We speculate that this is related to the small sample size due to difficulty in recruiting. Further studies with an effective recruitment method and larger sample sizes are needed to accurately verify the effectiveness of this program.

Citing Articles

Effect of a Smoking Cessation Education Program on the Knowledge, Attitude, and Self-Efficacy of Community Pharmacists in Japan: A Quasi-Experimental Study.

Onda M, Horiguchi M, Domichi M, Sakane N Tob Use Insights. 2024; 17:1179173X241272362.

PMID: 39131666 PMC: 11311180. DOI: 10.1177/1179173X241272362.


Systematic literature review of the impact of psychiatric pharmacists.

Ho J, Roberts J, Payne G, Holzum D, Wilkoff H, Tran T Ment Health Clin. 2024; 14(1):33-67.

PMID: 38312443 PMC: 10836561. DOI: 10.9740/mhc.2024.02.033.

References
1.
Schulz K, Altman D, Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332. PMC: 2844940. DOI: 10.1136/bmj.c332. View

2.
Shen X, Bachyrycz A, Anderson J, Tinker D, Raisch D . Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New Mexico. J Manag Care Spec Pharm. 2014; 20(6):579-87. PMC: 10437766. DOI: 10.18553/jmcp.2014.20.6.579. View

3.
Saffouh El Hajj M, Kheir N, Al Mulla A, Shami R, Fanous N, Mahfoud Z . Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial. BMC Public Health. 2017; 17(1):215. PMC: 5319062. DOI: 10.1186/s12889-017-4103-4. View

4.
Mdege N, Chindove S . Effectiveness of tobacco use cessation interventions delivered by pharmacy personnel: a systematic review. Res Social Adm Pharm. 2013; 10(1):21-44. DOI: 10.1016/j.sapharm.2013.04.015. View

5.
Saba M, Diep J, Saini B, Dhippayom T . Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy. J Clin Pharm Ther. 2014; 39(3):240-7. DOI: 10.1111/jcpt.12131. View